STING1 and neoplasm: Previous studies have shown that RT can disrupt the DNA structure of tumor cells, resulting in a large number of DNA fragments in their cytoplasm, which activates the cGAS-STING pathway, thereby causing the release of IFN-I and inducing a stronger anti-tumor immune response [21–24].